Some of the potential advantages of industry consortiums for technology in clinical trials development include risk reduction through joint investment in joint projects, the inclusion of multiple stakeholder perspectives (patients, investigators, treating clinicians, payers, regulators), obtaining interdisciplinary expertise in analytics, endpoint validation.